Studies characterizing 60 kDa autoantibodies in subjects with schizophrenia

Biological Psychiatry

Volumn 53, Issue 5, 2003, Pages 361-375

  Wang, Xiao Fen ^a   Wang, Dunrui ^a   Zhu, Weiguo ^b   Delrahim, Katia K ^c   Dolnak, Douglas ^b   Rapaport, Mark Hyman ^c  

^a VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Autoantibody; Autoantigen; Brain; Heat shock protein; Mental disorder; Protein associated with MYC (PAM); Schizophrenia

Indexed keywords

AUTOANTIBODY; HEAT SHOCK PROTEIN 60; PROTEIN; PROTEIN ASSOCIATED WITH MYC; UNCLASSIFIED DRUG;

ADULT; ANTIBODY AFFINITY; ANTIGEN ANTIBODY REACTION; ARTICLE; CONTROLLED STUDY; DNA LIBRARY; EPITHELIUM CELL; ESCHERICHIA COLI; FEMALE; GENE EXPRESSION SYSTEM; GENETIC TRANSCRIPTION; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MAJOR CLINICAL STUDY; MALE; MOLECULAR CLONING; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DATABASE; PROTEIN EXPRESSION; PROTEIN PURIFICATION; RNA TRANSLATION; SCHIZOPHRENIA; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

EID: 0037374086     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(02)01972-8     Document Type: Article

References (52)

1. Albert L.J., Inman R.D. Molecular mimicry and autoimmunity. N Engl J Med. 341:1999;2068-2074.
2. Andreasen N.C. The Scale for the Assessment of Negative Symptoms. 1981;The University of Iowa, Iowa City, IA.
3. Andreasen N.C. The Scale for the Assessment of Positive Symptoms. 1984;The University of Iowa, Iowa City, IA.
4. Bruce L.C., Peebles A.M.S. Clinical and experimental observations of catatonia. J Ment Sci. 49:1903;614-628.
5. Bruce L.C., Peebles A.M.S. Quantitative and qualitative leukocyte counts in various forms of mental diseases. J Ment Sci. 50:1904;409-417.
6. Burke B., Griffiths G., Reggio H., Louvard D., Warren G. A monoclonal antibody against a 135-K Golgi membrane protein. EMBO J. 1:1982;1621-1628.
7. Craft J., Fatenejad S. Self antigens and epitope spreading in systemic autoimmunity. Arthritis Rheum. 40:1997;1374-1382.
8. Dang C.V. C-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol Cell Biol. 19:1999;1-11.
9. Delrahim K., Rapaport M.H. An abbreviated review of immune abnormalities in schizophrenia. CNS Spectrums. 6:2001;392-397.
10. Fatenejad S., Mamula M.J., Craft J. Role of intermolecular/intrastructural B- and T-cell determinants in the diversification of autoantibodies to ribonucleoprotein particles. Proc Natl Acad Sci U S A. 90:1993;12010-12014.
11. First M.B., Spitzer R.L., Gibbon M., Williams J.B. Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version (SCID-CV). 1996;American Psychiatric Press, Washington, DC.
12. Ganguli R., Brar J.S., Chengappa K.N., Yang Z.W., Nimgaonkar V.L., Rabin B.S. Autoimmunity in schizophrenia A review of recent findings . Ann Med. 25:1993;489-496.
13. Ganguli R., Brar J.S., Rabin B.S. Immune abnormalities in schizophrenia Evidence for the autoimmune hypothesis . Harv Rev Psychiatry. 2:1994;70-83.
14. Guo Q., Xie J., Dang C.V., Liu E.T., Bishop J.M. Identification of a large Myc-binding protein that contains RCC1-like repeats. Proc Natl Acad Sci U S A. 95:1998;9172-9177.
15. Guy W. ECDEU Assessment Manual for Psychopharmacology, Revised. 1976;U.S. Department of Health, Education and Welfare, Washington, DC.
16. Hatakeyama M., Mori H., Doi T., Taniguchi T. A restricted cytoplasmic region of IL-2 receptor beta chain is essential for growth signal transduction but not for ligand binding and internalization. Cell. 59:1989;837-845.
17. Henneberg A.E., Horter S., Ruffert S. Increased prevalence of antibrain antibodies in the sera from schizophrenic patients. Schizophr Res. 14:1994;15-22.
18. Henneberg A.E., Ruffert S., Henneberg H., Kornhuber H.H. Antibodies to brain tissue in sera of schizophrenic patients - preliminary findings. Eur Arch Psychiatry Clin Neurosci. 242:1993;314-317.
19. Henriksson M., Luscher B. Proteins of the Myc network Essential regulators of cell growth and differentiation . Adv Cancer Res. 68:1996;109-182.
20. Jankovic B.D. From immunoneurology to immunopsychiatry Neuromodulating activity of anti-brain antibodies . Int Rev Neurobiol. 26:1985;249-314.
21. Jankovic B.D., Djordjijevic D. Differential appearance of autoantibodies to human brain S100 protein neuron specific enolase and myelin basic protein in psychiatric patients. Int J Neurosci. 60:1991;119-127.
22. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 13:1987;261-276.
23. Kilidireas K., Latov N., Strauss D.H., Gorig A.D., Hashim G.A., Gorman J.M., et al. Antibodies to the human 60 kDa heat-shock protein in patients with schizophrenia. Lancet. 340:1992;569-572.
24. Kim J.J., Lee S.J., Toh K.Y., Lee C.U., Lee C., Paik I.H. Identification of antibodies to heat shock proteins 90 kDa and 70 kDa in patients with schizophrenia. Schizophr Res. 52:2001;127-135.
25. Kirch D.G. Infection and autoimmunity as etiologic factors in schizophrenia A review and reappraisal . Schizophr Bull. 19:1993;355-370.
26. Klyushnik T.P., Danilovskaya E.V., Vatolkina O.E., Turkova I.L. Changes in the serum levels of autoantibody to nerve growth factor in patients with schizophrenia. Neurosci Behav Physiol. 29:1999;355-357.
27. Lehmann-Facius H. Über die Liquordiagnose der Schizophrenien. Klin Wochenschr. 16:1937;1646-1648.
28. Leonardi A, Cocito L (1982): CSF and serum IgG and albumin in schizophrenia. IRCS Medical Science Immunology and Allergy. Baltimore, MD: University Park Press, pp 1703-1704.
29. Leykin I., Spivac B., Weizman A., Cohen I.R., Shinitzky M. Elevated cellular immune response to human heat-shock protein-60 in schizophrenic patients. Eur Arch Psychiatry Clin Neurosci. 249:1999;238-246.
30. Maes M., Song C., Lin A., De Jongh R., Van Gastel A., Kenis G., et al. The effects of psychological stress on humans Increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety . Cytokine. 10:1998;313-318.
31. Marcu K.B., Bossone S.A., Patel A.J. Myc function and regulation. Annu Rev Biochem. 61:1992;809-860.
32. Mazeh D., Sirota P., Patya M., Novogrodsky A. Antibodies to neuroblastoma cell line proteins in patients with schizophrenia. J Neuroimmunol. 84:1998;218-222.
33. Miyazaki T., Liu Z.J., Kawahara A., Minami Y., Yamada K., Tsujimoto Y., et al. Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc, and lck cooperate in hematopoietic cell proliferation. Cell. 81:1995;223-231.
34. Mukherjee S., Mahadik S.P., Korenovsky A., Laev H., Schnur D.B., Reddy R. Serum antibodies to nicotinic acetylcholine receptors in schizophrenic patients. Schizophr Res. 12:1994;131-136.
35. Muller N., Riedel M., Gruber R., Ackenheil M., Schwarz M.J. The immune system and schizophrenia. An integrative view. Ann N Y Acad Sci. 917:2000;456-467.
36. Noy S., Achiron A., Laor N. Schizophrenia and autoimmunity - a possible etiological mechanism? Neuropsychobiology. 30:1994;157-159.
37. Oldstone M.B. Molecular mimicry and immune-mediated diseases. FASEB J. 12:1998;1255-1265.
38. Pandey R.S., Gupta A.K., Chaturvedi U.C. Autoimmune model of schizophrenia with special reference to antibrain antibodies. Biol Psychiatry. 16:1981;1123-1136.
39. Pollard KM, Chan EK, Tan EM (1995): Autoantibodies and autoimmunity. In: Meyers RA, editor. Molecular Biology and Biotechnology: A Comprehensive Desk Reference. New York, NY: VCH, pp 47-50.
40. Rapaport M.H., McAllister C.G., Kirch D.G., Pickar D. The effects of typical and atypical neuroleptics on mitogen-induced T lymphocyte responsiveness. Biol Psychiatry. 29:1991;715-717.
41. Rapaport M.H., McAllister C.G., Pickar D., Tamarkin L., Kirch D.G., Paul S.M. CSF IL-1 and IL-2 in medicated schizophrenic patients and normal volunteers. Schizophr Res. 25:1997;123-129.
42. Rapaport M.H., Muller N. Immunological states associated with schizophenia. Psychoneuroimmunology. 2:2001;372-382.
43. Rimon R., Ahokas A., Palo J. Serum and cerbrospinal fluid antibodies to cytomegalovirus in schizophrenia. Acta Psychiatr Scand. 73:1986;642-644.
44. Schwarz M.J., Riedel M., Gruber R., Ackenheil M., Muller N. Antibodies to heat shock proteins in schizophrenic patients Implications for the mechanism of the disease . Am J Psychiatry. 156:1999;1103-1104.
45. Tan E.M. Autoantibodies in pathology and cell biology. Cell. 67:1991;841-842.
46. Teplizki H.A., Sela B., Shoenfeld Y. Autoantibodies to brain and polynucleotides in patients with schizophrenia A puzzle . Immunol Res. 11:1992;66-73.
47. Torrey E.F., Peterson M.R., Brannon W.L. Immunoglobulins and viral antibodies in psychaitric patients. Br J Psychiatry. 132:1978;342-348.
48. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets Procedure and some applications . Proc Natl Acad Sci U S A. 76:1979;4350-4354.
49. Wang D., Buyon J.P., Zhu W., Chan E.K.L. Defining a novel 75 kDa phosphoprotein associated with the 60 kDa SS-A/Ro and identification of distinct human autoantibodies. J Clin Invest. 104:1999;1265-1275.
50. Yang Z.W., Chengappa K.N., Shurin G., Brar J.S., Rabin B.S., Gubbi A.V., et al. An association between anti-hippocampal antibody concentration and lymphocyte production of IL-2 in patients with schizophrenia. Psychol Med. 24:1994;449-455.
51. Yolken R.H., Torrey E.F. Viruses, schizophrenia, and bipolar disorder. Clin Microbiol Rev. 8:1995;131-145.
52. Zarrabi M.H., Zucker S., Miller F., Derman R.M., Romano G.S., Hartnett J.A., et al. Immunologic and coagulation disorders in chlorpromazine-treated patients. Ann Intern Med. 91:1979;194-199.